mycosis fungoides-type cutaneous T-cell lymphoma
September 24, 2013
Cancer Drug Developed by UAMS Professor Receives FDA Approval
Sept. 24, 2013 | Valchlor, a breakthrough gel for treating lymphoma developed with the help of University of Arkansas for Medical Sciences (UAMS) College of Pharmacy Professor Peter Crooks, Ph.D., recently won marketing approval from the U.S. Food and Drug Administration.
Cancer Drug Developed by UAMS Professor Awarded FDA Approval
LITTLE ROCK — Valchlor, a breakthrough gel for treating lymphoma developed with the help of University of Arkansas for Medical Sciences (UAMS) College of Pharmacy Professor Peter Crooks, Ph.D., recently won marketing approval from the U.S. Food and Drug Administration.